Colon X-ray proves it effectiveness at spotting cancer
September 17, 2008 by admin · Leave a Comment
A long-awaited federal study of an X-ray alternative to the dreaded colonoscopy confirms its effectiveness at spotting most cancers, although it was far from perfect.
Medicare is already considering paying for this cheaper, less intrusive option that could persuade more people to get screened for colon cancer. And some experts believe the new method may boost the 50 percent screening rate for a cancer that is the country’s second biggest killer.
Researchers identify cancer-causing gene in many colon cancers
September 14, 2008 by admin · Leave a Comment
Demonstrating that despite the large number of cancer-causing genes already identified, many more remain to be found, scientists at Dana-Farber Cancer Institute have linked a previously unsuspected gene, CDK8, to colon cancer.
Scientists discover major genetic cause of colorectal cancer
August 15, 2008 by admin · Leave a Comment
Hikes risk of developing cancer to 50 percent
About one-third of colorectal cancers are inherited, but the genetic cause of most of these cancers is unknown. The genes linked to colorectal cancer account for less than 5 percent of all cases.
MIT researchers see alternative to common colorectal cancer drug
June 17, 2008 by admin · Leave a Comment
A compound that accumulates in cells more readily than a commonly used colorectal cancer drug may be just as useful in treating colorectal tumors, but with fewer side effects, MIT researchers have found.
Weill Cornell Team Identifies New Cancer Stem Cell Driving Metastatic Tumors
May 27, 2008 by admin · Leave a Comment
CD133- Cells Can Initiate Metastatic Disease, Could Redirect Cancer Research
The molecular profile of cancer stem cells that initiate metastatic colon tumors is significantly different from those responsible for primary tumors, according to new research from a team at Weill Cornell Medical College.
A novel hMSH2 gene mutation in colorectal cancer patients?
February 25, 2008 by admin · Leave a Comment
About 20% CRC patients have a genetic component and HNPCC is the most common autosomal dominant hereditary syndrome. Some Chinese HNPCC pedigrees were recently reported in the January 14, 2008 issue of the World Journal of Gastroenterology because of their great significance for hereditary CRC. This article will undoubtedly bring comfort to many families.
Protein Blocker Stops Colon Cancer
January 28, 2008 by admin · Leave a Comment
Blocking a protein in mice can keep the inflammatory bowel disease ulcerative colitis (UC) from turning into colon cancer.
UC is characterized by bouts of bloody diarrhea that can last for months and recurs. It often progresses to colon cancer.
Regular, long-term aspirin use reduces risk of colorectal cancer
January 22, 2008 by admin · Leave a Comment
Patients need to talk to their doctor to discuss risks vs. benefits
The use of regular, long-term aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) reduces the risk associated with colorectal cancer, according to a study published in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. However, the use of aspirin for chemoprevention of colorectal cancer may require using the drug at doses that are higher than recommended over a long period of time, which may cause serious side effects including gastrointestinal bleeding.
Colon cancer risk in US traced to common ancester
January 2, 2008 by admin · Leave a Comment
Discovery of founder mutation involves 2 large families in Utah, New York
A married couple who sailed from England to America around 1630 may be the ancestors of hundreds of people alive today who are at risk for a hereditary form of colon cancer.
Bowel cancer screening halves emergency admissions and cuts deaths
November 30, 2007 by admin · Leave a Comment
The effects of population based fecal occult blood test screening upon emergency colorectal cancer admissions in Coventry and North Warwickshire
Bowel cancer screening halves emergency admissions for the disease and significantly cuts death rates, reveal the fifth year results from one of the first UK pilot sites.
